A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...
今後のがん研究において大きな役割を果たすことが期待される、ゲノム編集技術「CRISPR/Cas9 (クリスパー・キャスナイン)」を活用した臨床試験の申請が、アメリカ国立衛生研究所 (NIH)の「組み換えDNA諮問委員会 (RAC)」の審議を通過しました。
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
米国食品医薬品局（FDA）は、バーテックス・ファーマシューティカルズ（Vertex Pharmaceuticals）とCRISPRセラピューティクス（CRISPR Therapeutics）が開発したCasgevy（キャスジェビイ）という遺伝子編集技術治療法を、重篤な血液疾患である輸血依存型β（ベータ）サラセミアの治療に用いることを 承認した。
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
Genetic modifications in reproductive cells, such as eggs, sperm, or embryos, are commonly referred to as germline editing and are heritable. 1 CRISPR-Cas 9, which stands for clustered regularly ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する